Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Den nåværende markedsprisen på Moderna Inc er 1 885,14 kr, med et 24-timers handelsvolum på 24,08B kr. Eiendelens markedsverdi er 752,83B kr, etter en endring på -0.18% det siste døgnet.
Tokenisert Moderna Inc handles til 1 887,11 kr, med en tokenisert markedsverdi på 17,52M kr og et 24-timers handelsvolum på 27,29M kr. Den tokeniserte eiendelen har beveget seg -1.11% i løpet av de siste 24 timene.